跳转至内容
Merck

E2387

Sigma-Aldrich

NECA

≥98% (TLC), powder, adenosine receptor agonist

别名:

乙基咔唑

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C12H16N6O4
CAS号:
分子量:
308.29
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

产品名称

5'-(N-乙基羧酰胺基)腺苷, powder

形狀

powder

品質等級

顏色

white

溶解度

45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.2 mg/mL (Solutions may be stored for several days at 4 °C.)
DMSO: 14 mg/mL (Solutions may be stored for several days at 4 °C.)
0.1 M HCl: 3.4 mg/mL (Solutions may be stored for several days at 4 °C.)
H2O: insoluble
ethanol: soluble (Solutions may be stored for several days at 4 °C.)

儲存溫度

2-8°C

SMILES 字串

CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(N)ncnc23

InChI

1S/C12H16N6O4/c1-2-14-11(21)8-6(19)7(20)12(22-8)18-4-17-5-9(13)15-3-16-10(5)18/h3-4,6-8,12,19-20H,2H2,1H3,(H,14,21)(H2,13,15,16)/t6-,7+,8-,12+/m0/s1

InChI 密鑰

JADDQZYHOWSFJD-FLNNQWSLSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

5′-(N-乙基酰胺基)腺苷通过 A2-腺苷受体激活刺激肺循环中的血管舒张。

應用

5′-(N-乙基酰胺基)腺苷用于:
  • 纯化癸基麦芽糖苷(DM)中的人腺苷A2A受体(A2AR)
  • 确定腺苷受体非特异性结合情况
  • 通过竞争性测定研究腺苷2B受体(RA2B)的作用机理

生化/生理作用

强效腺苷受体激动剂与 A 1 和 A 2 受体的亲和力几乎相等。

特點和優勢

《受体分类和信号转导》手册的 腺苷受体页有该化合物的介绍。想要浏览手册的其他页面, 请单击此处

象形圖

Skull and crossbones

訊號詞

Danger

危險聲明

防範說明

危險分類

Acute Tox. 2 Oral

儲存類別代碼

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Olov Andersson et al.
Cell metabolism, 15(6), 885-894 (2012-05-23)
Diabetes can be controlled with insulin injections, but a curative approach that restores the number of insulin-producing β cells is still needed. Using a zebrafish model of diabetes, we screened ~7,000 small molecules to identify enhancers of β cell regeneration.
Jhansi Rani Nathan et al.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 84, 1406-1418 (2016-11-03)
Angiogenesis, formation of new blood vessels is an important process involved in neovascular diseases and tumor progression. Understanding and defining novel therapeutic targets of neovascular diseases like retinopathy of prematurity, diabetic retinopathy and age-related macular degeneration have been hindered by
Expression, purification and crystallisation of the adenosine A2A Receptor Bound to an Engineered Mini G Protein
Carpenter B and Tate CG
Bio-protocol, 7(8) (2017)
Docking screens for dual inhibitors of disparate drug targets for Parkinson?s disease
Jaiteh M, et al.
Journal of Medicinal Chemistry, 61(12), 5269-5278 (2018)
Nanomolar anti-sickling compounds identified by ligand-based pharmacophore approach
Paz OS, et al.
European Journal of Medicinal Chemistry, 136, 487-496 (2017)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门